Associated Papers
Serum HDL-cholesterol is associated with the clinical-biological profile of early-stage Parkinson's disease patients independently of APOE.
Mascioli D et al.
Neurobiology of Aging, 2025
Exploring the effect of APOE ε4 on biomarkers of neurodegeneration in Alzheimer's disease.
Agnello L et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2024
Analysis of endothelial gene polymorphisms in Spanish patients with vascular dementia and Alzheimer´s disease.
Manso-Calderón R et al.
Scientific Reports, 2023
Increase of serum uric acid levels associated with APOE ε2 haplotype: a clinico-genetic investigation and in vivo approach.
Ogura M et al.
Human Cell, 2021
Trace elements and APOE polymorphisms in pregnant women and their new-borns.
Trdin A et al.
Environment International, 2020
Apolipoprotein E Gene Polymorphism, Glycated Hemoglobin, and Peripheral Arterial Disease Risk in Chinese Type 2 Diabetic Patients.
Hu Y et al.
Disease Markers, 2020
Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.
Arrigoni E et al.
International Journal of Molecular Sciences, 2017
TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
Mise A et al.
Journal of Alzheimer's Disease : Jad, 2017
Influence of APOE Gene Polymorphism on Interindividual and Interethnic Warfarin Dosage Requirement: A Systematic Review and Meta-Analysis.
Yu WY et al.
Cardiovascular Therapeutics, 2016
The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis.
Pleva L et al.
Bmc Cardiovascular Disorders, 2015
Association of ApoE gene with type 2 diabetic nephropathy in a Chinese population: a meta-analysis of case-control studies.
Zhang C et al.
Annales D'endocrinologie, 2015
The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.
Linnertz C et al.
Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2014
Genetic markers associated to dyslipidemia in HIV-infected individuals on HAART.
Lazzaretti RK et al.
Thescientificworldjournal, 2013
Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.
Soares HD et al.
Archives of Neurology, 2012
Apolipoprotein E ε2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease.
Bonner-Jackson A et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry, 2012
Characterization of the poly-T variant in the TOMM40 gene in diverse populations.
Linnertz C et al.
Plos One, 2012
Potential utility of soluble p3-alcadein α plasma levels as a biomarker for sporadic Alzheimer's disease.
Kamogawa K et al.
Journal of Alzheimer's Disease : Jad, 2012
The APOE -219G/T and +113G/C polymorphisms affect insulin resistance among Turks.
Komurcu-Bayrak E et al.
Metabolism: Clinical and Experimental, 2011
COMT Val158Met Genotype and Individual Differences in Executive Function in Healthy Adults.
Wishart HA et al.
Journal of the International Neuropsychological Society : Jins, 2011
Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily).
Hu M et al.
The American Journal of Cardiology, 2010
Apolipoprotein A-I positively associated with diabetes in women independently of apolipoprotein E genotype and apolipoprotein B levels.
Onat A et al.
Nutrition (burbank, Los Angeles County, Calif.), 2010
Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers.
Dennis NA et al.
Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2010
Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down syndrome.
Prasher VP et al.
International Journal of Geriatric Psychiatry, 2008
Robust association of the APOE epsilon4 allele with premature myocardial infarction especially in patients without hypercholesterolaemia: the Aachen study.
Schmitz F et al.
European Journal of Clinical Investigation, 2007
Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus.
Tavintharan S et al.
Diabetes, Obesity & Metabolism, 2007
New insight into the association of apolipoprotein E genetic variants with carotid plaques and intima-media thickness.
Debette S et al.
Stroke, 2006
Warfarin dose related to apolipoprotein E (APOE) genotype.
Kohnke H et al.
European Journal of Clinical Pharmacology, 2005
Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting.
Koch W et al.
Journal of Lipid Research, 2004
Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.
Bray NJ et al.
Human Molecular Genetics, 2004
TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E.
Koch W et al.
Clinical Chemistry and Laboratory Medicine, 2002